Quarterly report pursuant to Section 13 or 15(d)

Other Current Liabilities

v3.21.2
Other Current Liabilities
 9 Months Ended
Sep. 30, 2021
Other Liabilities Disclosure [Abstract]  
Other Current Liabilities

Note 9 - Other Current Liabilities

 

The following table sets forth the components of other current liabilities at September 30, 2021 and December 31, 2020, respectively (in thousands):

 

    September 30,     December 31,  
    2021     2020  
Accrued commissions   $ 1,054     $ 461  
Accrued payroll     56       464  
Accrued expenses     251       304  
Accrued returns     331       291  
Accrued income tax payable     -       8  
Accrued benefits and vacation     49       34  
Deferred revenue     -       169  
Total other current liabilities   $ 1,741     $ 1,731  

 

 

ProPhase Labs, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(unaudited)